Italian drugmakers Alfa Wasserman and Sigma-Tau said on Thursday they had agreed to merge pharmaceutical activities to create a domestic champion with sales of more than 900 million euros ($992 million).
In October sources told Reuters the two companies were in advanced talks to combine their Italian operations.
{iframe}http://www.reuters.com/article/2015/03/05/sigmatau-alfawasserman-ma-idUSL5N0W75J620150305{/iframe}